HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, international biopharmaceutical firm targeted on growing differentiated molecules and mixture therapies for...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Prescribed drugs, Inc. (Nasdaq:ORIC), a medical stage oncology firm targeted...
NOVATO, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:), a biopharmaceutical firm targeted on the event and commercialization...
